Association of elevated plasma B-type natriuretic peptide levels with paroxysmal atrial fibrillation in patients with nonobstructive hypertrophic cardiomyopathy

Clinical Biochemistry

Volumn 41, Issue 3, 2008, Pages 134-139

  Matsuura, Hiroko ^a   Murakami, Takashi ^c   Hina, Kazuyoshi ^c   Yamamoto, Keizo ^c   Kawamura, Hiroshi ^c   Sogo, Taiji ^d   Shinohata, Ryoko ^b   Usui, Shinichi ^b   Ninomiya, Yoshifumi ^a   Kusachi, Shozo ^b  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c Sakakibara Hospital   (Japan)

^d TAKAMATSU RED CROSS HOSPITAL   (Japan)

Author keywords

Cardiomyopathy; Clinical study; Enzyme immunoassay; Peptide; Sensitivity and specificity; Tachyarrhythmia

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PAROXYSMAL TACHYCARDIA; PRIORITY JOURNAL;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CARDIOMYOPATHY, HYPERTROPHIC; CHRONIC DISEASE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FLUOROIMMUNOASSAY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; TACHYCARDIA, PAROXYSMAL;

EID: 38849146408     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.10.015     Document Type: Article

References (40)

1. Yasue H., Yoshimura M., Sumida H., et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90 (1994) 195-203
2. Ogawa Y., Nakao K., Mukoyama M., et al. Rat brain natriuretic peptide-tissue distribution and molecular form. Endocrinology 126 (1990) 2225-2227
3. Ogawa Y., Nakao K., Mukoyama M., et al. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circ Res 69 (1991) 491-500
4. Hama N., Itoh H., Shirakami G., et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92 (1995) 1558-1564
5. Hosoda K., Nakao K., Mukoyama M., et al. Expression of brain natriuretic peptide gene in human heart. Production in the ventricle. Hypertension 17 (1991) 1152-1155
6. Mukoyama M., Nakao K., Hosoda K., et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87 (1991) 1402-1412
7. Weber M., Arnold R., Rau M., et al. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J 26 (2005) 1023-1030
8. Omland T., Aakvaag A., and Vik-Mo H. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. Heart 76 (1996) 232-237
9. Rodeheffer R.J. Measuring plasma B-type natriuretic peptide in heart failure: good to go in 2004?. J Am Coll Cardiol 44 (2004) 740-749
10. Tsutamoto T., Wada A., Maeda K., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96 (1997) 509-516
11. Wallen T., Landahl S., Hedner T., Saito Y., Masuda I., and Nakao K. Brain natriuretic peptide in an elderly population. J Intern Med 242 (1997) 307-311
12. Silvet H., Young-Xu Y., Walleigh D., and Ravid S. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol 92 (2003) 1124-1127
13. Wozakowska-Kaplon B. Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation. Am J Cardiol 93 (2004) 1555-1558
14. Beck-da-Silva L., de Bold A., Fraser M., Williams K., and Haddad H. Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm. Can J Cardiol 20 (2004) 1245-1248
15. Vinch C.S., Rashkin J., Logsetty G., et al. Brain natriuretic peptide levels fall rapidly after cardioversion of atrial fibrillation to sinus rhythm. Cardiology 102 (2004) 188-193
16. Spirito P., Chiarella F., Carratino L., Berisso M.Z., Belloti P., and Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med 320 (1989) 749-755
17. Glancy D.L., O'Brien K.P., Gold H.K., and Epstein S.E. Atrial fibrillation in patients with idiopathic hypertrophic subaortic stenosis. Br Heart J 32 (1970) 652-659
18. Robinson K., Frenneaux M.P., Stockins B., Karatasakis G., Poloniecki J.D., and McKenna W.J. Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. J Am Coll Cardiol 15 (1990) 1279-1285
19. Maron B.J. Hypertrophic cardiomyopathy. Lancet 350 (1997) 127-133
20. Madariaga I., Carmona J.R., Mateas F.R., Lezaun R., and de los Arcos E. Supraventricular arrhythmia as the cause of sudden death in hypertrophic cardiomyopathy. Eur Heart J 15 (1994) 134-137
21. Cecchi F., Olivotto I., Montereggi A., Santoro G., Dolara A., and Maron B.J. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol 26 (1995) 1529-1536
22. Inoue S., Murakami Y., Sano K., Katoh H., and Shimada T. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 6 (2000) 92-96
23. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 27 (2006) 1979-2030
24. Nishikimi T., Yoshihara F., Morimoto A., et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 28 (1996) 22-30
25. Kono M., Yamaguchi A., Tsuji T., et al. An immunoradiometric assay for brain natriuretic peptide in human plasma (in Japanese with English abstract). Jpn J Nucl Med Technol 13 (1992) 2-7
26. Cheitlin M.D., Armstrong W.F., Aurigemma G.P., et al. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr 16 (2003) 1091-1110
27. Klues H.G., Schiffers A., and Maron B.J. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26 (1995) 1699-1708
28. Maron M.S., Olivotto I., Betocchi S., et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348 (2003) 295-303
29. Maron B.J., and Epstein SE. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol 43 (1979) 1242-1244
30. Knudsen C.W., Omland T., Clopton P., et al. Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study. J Am Coll Cardiol 46 (2005) 838-844
31. Lusted L.B. Decision-making studies in patient management. N Engl J Med 284 (1971) 416-424
32. Agresti A., and Coull B. Approximate is better than "exact" for interval estimation of binomial proportions. Am Stat 52 (1998) 119-126
33. Brown L., Cai T., and DasGupta A. Interval estimation for a binomial proportion (with discussion). Stat Sci 16 (2001) 101-133
34. Takeuchi I., Inomata T., Nishii M., et al. Clinical characteristics of heart disease patients with a good prognosis in spite of markedly increased plasma levels of type-B natriuretic peptide (BNP): anomalous behavior of plasma BNP in hypertrophic cardiomyopathy. Circ J 69 (2005) 277-282
35. Maron B.J., Tholakanahalli V.N., Zenovich A.G., et al. Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy. Circulation 109 (2004) 984-989
36. Engelmann M.D., Niemann L., Kanstrup I.L., Skagen K., and Godtfredsen J. Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation. Int J Cardiol 105 (2005) 31-39
37. Li J., and Wang L. B-type natriuretic peptide levels in patients with paroxysmal lone atrial fibrillation. Heart Vessels 21 (2006) 137-140
38. Tani T., Tanabe K., Ono M., et al. Left atrial volume and the risk of paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 17 (2004) 644-648
39. Ozdemir O., Soylu M., Demir A.D., et al. P-wave durations as a predictor for atrial fibrillation development in patients with hypertrophic cardiomyopathy. Int J Cardiol 94 (2004) 163-166
40. Cecchi F., Montereggi A., Olivotto I., Marconi P., Dolara A., and Maron B.J. Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal averaged P wave duration. Heart 78 (1997) 44-49